Key words UHPLC-TOF-HRMS - gendarusin A - 2-aminobenzyl derivatives - male contraception
Introduction
Justicia gendarussa Burm. F. (Acanthaceae) is a medicinal plant found in Sri-Lanka, India, Malaysia,
the Philippines, and Indonesia [1 ]. Traditionally, the leaves have been used for many illnesses, including rheumatoid
gout, arthritis, asthma, vaginal discharges, and headache [2 ]
[3 ]
[4 ]
[5 ], and their anti-inflammatory, analgesic [6 ], antioxidant, and hepatoprotective activities [7 ] have also been reported. Particularly remarkable is the male fertility reducing
activity of J. gendarussa leaves, used traditionally by the Indonesian Papuan people for male contraception
[8 ]
[9 ]. Apart from knowledge of it being used as a water decoction, there are, unfortunately,
few documented details about the traditional preparations [9 ]
[10 ].
The male contraceptive properties have gained interest in Indonesia for phytochemical
and pharmacological investigations. An ethanolic leaf extract of J. gendarussa obtained from the Pacet region (Indonesia) was phytochemically investigated and 6,8-di-C-α -L -arabinocylapigenin (gendarusin A) was identified as the major constituent [11 ]
[12 ]. Also identified was another less abundant flavonoid, C glycoside gendarusin B (6-C-α -L -arabinocyl-8-C-β -D-xylocilapigenin) [11 ]
[12 ], and more recently, unusual 2-aminobenzyl derivatives (justidrusamides A-D) [13 ]. O -Substituted aromatic amines [14 ], β -sitosterol, lupenol, and fridelin [15 ] were reported to be present in J. gendarussa collected in India.
Gendarusin A was reported to reversibly inhibit the activity of spermatozoa hyaluronidase
activity [11 ]
[12 ], which is a facilitating enzyme for sperm penetration during in vitro fertilisation [11 ]
[16 ]; therefore, gendarusin A is considered to be the active constituent for the male
contraceptive property of J. gendarussa. Currently, the gendarusin A flavonoid-enriched extract of J. gendarussa leaves is reportedly under clinical trials as a male contraceptive in Indonesia [12 ]. These extracts undergo an extensive “cleaning” standardisation process to improve
their safety profile [12 ]
[17 ].
Given the fact that the plant is also used by Papuans without any pretreatment, we
thought comparative chemical profiling of the enriched extracts and the traditional
water decoction was important to underline any chemical differences. We compared different
J. gendarussa samples from other regions for the presence of the active compound and other major
constituents to facilitate the future selection of J. gendarussa plant specimens with the highest content of the active constituent for cultivation.
The extracts of J. gendarussa leaves collected in different regions of Indonesia as well as traditional water decoctions
and enriched extracts were comparatively profiled for their main active constituent
content (gendarusin A) and other major chemical markers. In the absence of available
certified reference standards, the main active constituent flavonoid (gendarusin A),
another main flavonoid (gendarusin B), and amide constituents (justidrusamides A-D)
were isolated for use as standards for the quantitation. A detailed comparison of
the traditional decoction and the enriched extract was established and the content
of the main compounds in J. gendarussa from various regions of Indonesia was compared from a quantitative view point.
Results and Discussion
In order to obtain a detailed survey of the composition of the leaves of J. gendarussa , a preliminary metabolite profiling was performed on the methanol leaf extract (see
experiment) using reversed-phase HPLC-PDA-ESI-MS and high-resolution UHPLC-TOF-HRMS
([Fig. 1 ]). The evaporative light scattering detector (ELSD) trace revealed that three main
constituent peaks, 4 [retention time (RT) 18.62 min], 5 (RT 20.67 min), and 6 (RT 23.31 min), were present in the extract as well as a large amount of very polar
constituents, mainly sugars, not retained on C18 (RT 2.6 min). The PDA and MS spectra of these main constituents enabled the dereplication
of 6 as the flavonoid C glycoside gendarusin A (UV PDA spectra: λ
max 245, 352 nm; HRMS [M - H]- at m/z 533.1347) [11 ]
[12 ] and peaks 4 and 5 as the pair of 2-aminobenzyl derivatives, isomeric justidrusamide A or B [13 ] (UV PDA spectra: λ
max 204, 236 nm; HRMS [M - H]- at m/z 368.1365 and 368.1374, respectively).
Fig. 1 HPLC-PDA-ELSD analysis of J. gendarussa methanol extract.
Other minor constituents still detectable by ELSD were, on one hand, the isomer of
gendarusin A, gendarusin B (7 ), which exhibited the same m/z ion and chromophore as compound 6 and, on the other hand, three additional 2-aminobenzyl derivatives (1 -3 ) all exhibiting the same chromophore (UV PDA spectra: λ
max 204, 236 nm; [Fig. 1 ]).
Peaks 2 and 3 displayed [M - H]- at m/z 384.1282 and 384.1297 in agreement with the molecular formula C17 H22 NO9 and were dereplicated as the two other isomeric pairs of justidrusamide C or D [13 ]
[17 ]. Interestingly, 1 (justidrusamide E) also presented a chromophore of 2-aminobenzyl derivatives and
was found to be an isomer of 4 and 5 (HRMS [M - H]- at m/z 368.1356). The polarity and online data indicated that 1 (justidrusamide E) was a 2-aminobenzyl derivative that potentially had not been previously
described. Since 4 , 5 , and 6 were the main compounds found in the leaf ([Fig. 1 ]), these three compounds were isolated to be used as standards for their quantitation
in the traditional decoction, enriched extract used for clinical trials, and leaf
extracts of J. gendarussa used from different Indonesian regions.
In order to unambiguously identify compound 1 and to obtain enough amount of the standards for the quantitation of 4 -6 , a crude methanol extract was fractionated. For an efficient and rational isolation,
a direct transfer of the analytical HPLC conditions to MPLC was performed using the
same reversed-phase material [18 ]. This procedure resulted in the isolation of six compounds from 3 g of crude methanol
extract (1 , 2 , 3 , 4 -6 ). Their full de novo identification was performed based on 1D and 2D NMR and HRMS experiments. In accordance
with the dereplication results, the identity of recently reported amides [13 ] justidrusamide D (2 ), justidrusamide C (3 ), justidrusamide A (4 ), and justidrusamide B (5 ) and the main flavonoid gendarusin A (6 ) [11 ]
[12 ] was confirmed. In addition, 1 was found to be a new 2-aminobenzyl derivative and, as indicated from dereplication,
probably a new compound not previously described. Its identification is described
below.
Compound 1 was isolated as an amorphous solid. The ESI-HRMS spectrum showed a molecular ion
at m/z 368.1356 [M - H]- , (calcd. for C17 H22 NO8 , 368.1345; Δ ppm=3.0). The NMR data of 1 showed strong similarities with those of justidrusamide D (2 ) [13 ]. The data was indeed consistent with the presence of a 5-hydroxy-2-aminobenzyl alcohol
group [δ
H 6.76 (1 H, dd, J =8.5, 2.9 Hz, H-4), 7.00 (1 H, d, J =2.9 Hz, H-6), 7.05 (1 H, d, J =8.5 Hz, H-3), and 4.94 (2 H, s, H-17)] and a 2,3-dihydroxy-2-(1-hydroxyethyl) butanoic
acid group [δ
H 1.04 (3 H, d, J =6.4 Hz, CH3 -13), 1.05 (3 H, d, J =6.4 Hz, CH3 -11), and 3.88 (2 H, q, J =6.4 Hz, H-10, 12)]. Compound 1 differed from 2 at the level of the succinic acid moiety where an additional methine was observed
at δ
H 5.14 (1 H, d, J =4.5 Hz, H-4') and δ
C 93.0. The COSY correlation between H-4' and the methylene CH2 -3' [δ
H 2.33 and 2.54] between CH2 -3' and CH2 -2' [δ
H 2.00 and 2.33] as well as the HMBC correlations from H-4' to CH2 -3' [δ
C 28.4] and to the ester carbonyl C-1' [δ
C 174.2] indicated that the succinic acid was cyclised in 1 to form a hydroxy-oxopyrrolidin group. Based on these results, 1 was identified as 5-hydroxy-2-(2-hydroxy-5-oxopyrrolidin-1-yl)benzyl(3 R )-2,3-dihydroxy-2-((R )-1-hydroxyethyl)butanoate, a new 2-aminobenzyl derivative named justidrusamide E
([Fig. 2 ]).
Fig. 2 Compounds isolated from J. gendarussa methanol extract.
The HPLC-UV method developed for the qualitative profiling was used for the quantitation
of the three main metabolites (4 -6 ) and for comparison of the content of various extracts (see experiment). The method
was validated for linearity, limits of detection (LOD), limits of quantification (LOQ),
and for precision and accuracy using already isolated and identified compounds (see
above) [19 ].
The linearity range for each compound was measured at a minimum of six different concentrations
on each calibration curve (n=6). Calibration curves were constructed by plotting injected
concentrations of the standard analytes (X) vs. their peak areas (Y). Good linearity
was observed by the linear regression analyses in a large range of concentrations:
1–800 µg/mL for compound 4 (R2 =0.999), 1–800 µg/mL for compound 5 (R2 =0.998), and 1–100 µg/mL for compound 6 (R2 =0.998) ([Table 1 ]).
Table 1 Linear range, LOD, and LOQ of the three compounds (n=6).
Compounda
Linearity range (µg/mL)
Calibration equationb
LOQ (µg/mL)c
LOD (µg/mL)c
R2d
RSDe
4
1-800
y=695.45x - 12.682
0.024
0.008
0.999
1.74
5
1-500
y=167.95x+16.155
0.119
0.03
0.997
2.01
6
1-100
y=98.195x+1.316
0.889
0.293
0.998
8.73
a 4 - Justidrusamide A, 5 - justidrusamide B, 6 - gendarusin A.
b
y and x are the peak areas and concentrations of the analytes (µg/mL), respectively.
c
The LOQ was defined as the concentrations at which the signal-to-noise ratio was 10,
and the LOD was defined as the concentration at which the signal-to-noise ratio was
3.3.
d
Calibration range correlation factor (R2 ).
e
Relative standard deviation (RSD%)
The LOQ and LOD were calculated by determining the standard deviation of the response
and the slope of the linear equation. LOD was found to be 0.008, 0.013, and 0.293 µg/mL
for 4 , 5 , and 6 , respectively, and the corresponding LOQ was 0.024, 0.039, and 0.889 µg/mL for 4 , 5 , and 6 , respectively ([Table 1 ]).
The precision of the assay was determined by measuring intraday (repeatability) and
inter-day (intermediate) variations (expressed as RSD%) at three concentrations included
on the calibration curve ([Table 2 ]). These solutions were prepared independently from the calibration solutions. Intraday
variation was determined by analysing six replicates of known concentrations using
the same preparation procedure within a single day (n=6). Inter-day precision was
determined in duplicate on 3 consecutive days (n=6). The RSD% of the peak areas and
retention times were calculated and the results are summarised in [Table 2 ].
Table 2 Inter-day and intraday precision of the method (n=6).
Reference standard concentrations (µg/mL) a
Inter-dayb RTc RSDd Areae RSD
Intradayb RT RSD Area RSD
Compound 4
0.5
18.68 0.06 31.63 2.67
18.65 0.03 29.63 12.82
300
18.67 0.09 1999.4 1.21
18.63 0.04 1446.2 1.97
800
18.65 0.06 5555.32 2.11
18.59 0.04 5066.7 0.89
Compound 5
5
20.72 0.07 10.46 2.06
20.82 0.08 7.25 4.83
50
20.71 0.11 108.56 1.53
20.69 0.06 85.96 1.56
300
20.66 0.01 517.76 2.28
20.66 0.01 528.75 2.27
Compound 6
1
23.44 0.19 5.5 2.40
23.42 0.19 5.53 2.95
10
23.42 0.26 11.13 1.13
23.46 0.03 12.35 2.88
100
23.40 0.18 92.2 0.44
23.34 0.17 105.87 2.83
a 4 - Justidrusamide A, 5 - justidrusamide B, 6 - gendarusin A. b Inter-day analyses were carried out in duplicate within 3 days (n=6), and intraday
analyses were carried in six replicates within a single day (n=6). c Mean retention time (min). d Relative standard deviation (%). e Peak mean area
The intraday and inter-day RSD% did not exceed the allowed 15%, which is in accordance
with the bioanalytical method validation guidelines of the Food and Drug Administration
[19 ]. Matrix effects were evaluated using recovery studies by the standard addition method.
Known concentrations of standard compounds (4 and 6 at 50 µg/ mL, 5 at 20 µg/ mL) were spiked into a pre-analysed J. gendarussa methanol crude extract (1000 µg/ mL) and reanalysed ([Table 3 ]). The mean recovery for all compounds was 95% and within the acceptable upper limit
of 120% (105, 103, and 104% for compounds 4 , 5 , and 6 , respectively; [Table 3 ]).
Table 3 Recovery studies of justidrusamide A (4 ), justidrusamide B (5 ), and gendarusin A (6 ) from the J. gendarussa extract (n=3).
Compound
Added concentrations (µg/mL)
Recovery
RSD%
4
50
105
0.55
5
20
103
0.17
6
50
104
6.83
For method reproducibility, the water decoction, enriched extract, and methanol extracts
of J. gendarussa from various regions were analysed using the validated method. Results expressed
as RSD% of the mean RT of compounds 4 , 5 , and 6 (n=3) indicated good reproducibility of the method (RSD%<1%; [Table 4 ]).
Table 4 Retention time reproducibility of justidrusamide A (4 ), justidrusamide B (5 ), and gendarusin A (6 ) in five different J. gendarussa leaf preparations extracted and analysed separately (n=3).
Purwodadia RTc RSDd
Cibodasa RT RSD
Gempola RT RSD
Paceta RT RSD
Waterb decoction RT RSD
Enrichedb extract RT RSD
4
18.59 0.04
18.62 0.04
18.60 0.04
18.65 0.36
18.62 0.02
18.68 0.04
5
20.69 0.04
20.67 0.12
20.69 0.04
20.70 0.08
20.72 0.02
20.79 0.05
6
23.25 0.05
23.31 0.08
23.27 0.06
23.28 0.12
23.30 0.02
23.39 0.05
a J. gendarussa leaves from Purwodadi, Cibodas, Gempol, and Pacet regions in Indonesia. b Water decoction and enriched extract prepared from J. gendarussa leaves. c Mean retention time (min). d Relative standard deviation (%)
Comparison of the UV profiles of the water decoction and enriched extract ([Fig. 3 ]) confirmed that gendarusin A (6 ) is the major compound in both of the extracts. Furthermore, UV and ELSD results
indicated that 4 and 5 (justidrusamides A and B) were at negligible amounts in the enriched extract, while
the decoction still contained both in significant amounts. In the ELSD trace of the
enriched extract, the peaks corresponding to the 2-aminobenzyl derivatives (1 -3 ) were not detected. These results suggest that the acid-base extraction used for
the preparation of the enriched extract for clinical studies removes the amides (see
experiment). In the trials, the enriched extract was used once daily at a 450-mg dosage,
indicating that the volunteers received 16.40 mg±1.26, w/w active compound gendarusin
A (6 ) daily, while compounds 4 and 5 were kept at very low concentrations (0.01 mg±0.52 and 0.05 mg±0.05, w/w, respectively).
Furthermore, as can be seen in [Fig. 4 ], the enriched extract at a 450-mg dosage still contained more active gendarusin
A (16.40 mg±1.26) than the 1 g dry leaf (12.45 mg±0.79) used for the decoction preparation,
highlighting that the enriching process during the extraction is an important step
to secure a high content of the active compound in the final yield.
Fig. 3 HPLC-PDA-ESLD analysis of J. gendarussa -enriched extract and water decoction.
Fig. 4 Comparison of the justidrusamide A (4 ), justidrusamide B (5 ), and gendarusin A (6 ) amounts (mg, w/w) found in 1 g dry leaf of J. gendarussa used for the decoction and in the clinical pill containing an enriched extract (450 mg);
n=3.
The water decoction presented a similar qualitative profile to that of the methanol
extracts (Fig. 1S , Supporting Information). In order to facilitate future selection of J. gendarussa plant specimens with the highest content of the active principle 6 , different samples were compared. Dry leaves from various regions in Indonesia (Purwodadi,
Gempol, Cibodas, and Pacet) were exhaustively extracted by methanol (see experiment).
For quantitation, all samples were prepared at 10 mg/mL through appropriate dilution
of the stock solutions in 70/30, v/v MeOH-H2 O (see experiment). The HPLC-UV comparison of the methanol extracts revealed that
qualitatively all plants contained 1 -7 ([Fig. 5 ]) and that the influence of the geographic origin did not seem to be very significant
in the constituent makeup.
Fig. 5 HPLC-UV analysis (254 nm) of J. gendarussa methanol extracts from a Purwodadi, b Gempol, c Cibodas, and d Pacet.
Though the gendarusin A (6 ) remained the main constituent in all extracts, the amounts were different in all
four types of leaves. Purwodadi and Pacet dry leaves contained similarly high amounts
of the active compound 6 ([Fig. 6 ]), while leaves of the Cibodas had the lowest content. Similar results have been
reported elsewhere [17 ]. By contrast, Pacet and Gempol showed similar amounts of 5 (justidrusamide B). Such variation between the quantitative profiles of J. gendarussa leaves might be explained by the effect of cultivation practices in different geographical
regions in accordance with previous reports [17 ].
Fig. 6 Amounts of justidrusamide A (4 ), justidrusamide B (5 ), and gendarusin A (6 ) (mg, w/w) found in 1 g dry leaf of J. gendarussa from Cibodas, Purwodadi, Gempol, and Pacet; n=3.
Therefore, to have the highest antifertility effectiveness, it is necessary to have
J. gendarussa leaves from the regions highest in gendarusin A, i. e., Purwodadi and Pacet. However,
more studies on the effects of seasonal variations on the quantitative content of
gendarusin A should be undertaken. The gendarusin A content was also found to be higher
in the enriched extract containing the pill used for the clinical studies, but lesser
than the extracts, which can be explained by the different extraction protocols used.
Overall, J. gendarussa leaves had similar chemical qualitative profiles independent from the geographical
regions in Indonesia, however, they were quantitatively different. Cibodas leaves
had the lowest amount of the active principle, gendarusin A (6 ), with about fourfold less flavonoid than the sample collected in Purwodadi, which
is most probably due to the geographical region of cultivation (soil, temperature,
etc.). The extract used in clinical trials contained mainly gendarusin A, as for the
traditional decoction, but the level of the aminobenzyl derivatives was significantly
lower. Qualitatively, all compounds isolated from J. gendarussa leaves were found in the traditional preparation (decoction). The water decoction
still contained significant, although lesser amounts, of the active compound 6 compared to both the extracts and enriched extracts, which is encouraging for traditional
users when taking into consideration their relatively simple method of preparation.
Nevertheless, the decoction also contained aminobenzyl derivatives, which were absent
in the enriched extract, and therefore the toxicology of these compounds should be
considered in order to mitigate any delayed adverse effects amongst traditional users.
Materials and Methods
General experimental procedures
UV spectra were measured on a PerkinElmer Lambda 20 spectrophotometer. NMR spectroscopic
data were recorded on a 500 MHz Varian Inova spectrometer. Chemical shifts are reported
in parts per million (δ ) using the residual CD3 OD signal (δ
H 3.31; δ
C 49.0) or DMSO-d
6 signal (δ
H 2.50; δ
C 39.5) as internal standards for 1 H and 13 C NMR, and coupling constants (J ) are reported in Hz. Complete assignment was performed based on 2D experiments (COSY,
TOCSY, NOESY, edited-HSQC, and HMBC). ESI-HRMS data were obtained on a Micromass LCT
Premier time-of-flight mass spectrometer from Waters with an electrospray ionisation
(ESI) interface. Analytical HPLC was performed using an HP 1100 system equipped with
a photodiode array detector (Agilent Technologies) using an X-Bridge RP C18 column (5 μm, 250×10 mm, i.d.; Waters). MPLC was performed using a modular Büchi
MPLC system equipped with a 681 pump module C-615, UV-Vis detector module C-640, and
Fraction collector module C-660, as well as a 460×70 mm i.d. column (Büchi) loaded
with Zeoprep® C18 as the stationary phase (15-25 μm; Zeochem).
Chemicals
HPLC-PDA-ESI-MS analysis was performed with H2 O (Millipore) and MeOH HPLC grade (Fisher Scientific). UPLC-TOF-HRMS analysis was
performed with H2 O and acetonitrile UPLC-MS grade (Biosolve). MPLC-UV isolation was performed with
H2 O (Millipore) and MeOH (technical grade). The MS was calibrated using sodium formate
and leucine-enkephalin, both from Sigma-Aldrich. In HPLC, MPLC, and HRMS analyses,
formic acid (FA) was used as the organic modifier (Sigma-Aldrich).
Plant material
Leaves of J. gendarussa werre collected in Pacet (East Java), Purwodadi (East Java), Cibodas (West Java),
and Gempol (East Java), Indonesia, in the period between 2012 and 2013 by Prof. B.
Prajogo. The botanical material was identified by the Indonesian Institute of Sciences
(LIPI). A voucher specimen was deposited at the Pharmaceutical Botany Laboratory,
Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia. The voucher numbers
are: J. gendarussa collected in Surabaya No 03/2012; J. gendarussa collected in Purwodadi No 05/2012; J. gendarussa collected in Pacet No 04/2012; J. gendarussa collected in Gempol No 01/2012; J. gendarussa collected in Cibodas No 07/2013. The dried leaf powder upon receipt was stored in a cold, dark, ventilated
room.
Increasing polarity extraction
The dried leaf powder of J. gendarussa (200 g) collected in Pacet (Mojokerto, East Java) was extracted using mechanical
agitation by maceration with solvents in the order of increasing polarity: hexane,
dichloromethane, methanol, and water, respectively. The exhaustiveness of the extraction
was monitored by thin-layer chromatography using the Godin reagents [20 ]. The extracts were filtered and concentrated to dryness by rotatory evaporation
to yield 3.86 g of hexane (1.93%, w/w), 2.54 g of dichloromethane (1.27%, w/w), 20.07 g
of methanol (10.03%, w/w), and 37.91 g of water extract (18.95%, w/w). The methanol
extract was used for the metabolite profiling and isolation of the standards for quantitation.
The dried leaf powders of J. gendarussa from Purwodadi (2.13 g), Cibodas (2.00 g), and Gempol (2.08 g) were extracted using
the same procedure described above to produce a methanol extract yield (%) as follows:
Purwodadi (9.03%, w/w), Cibodas (5.94%, w/w), and Gempol (8.48%; 16.38%, w/w). The
dried extracts were kept at 4+°C until the analyses were performed. Samples were filtrated
with a 0.45-µm membrane filter prior to the HPLC analyses.
Water decoction preparation
The dried ground leaf powder (150 g) was soaked in boiling water (600 mL; Millipore)
under reflux for 1 h and then filtered under a vacuum pump. The filtrate was lyophilised
to produce the water decoction extract (18.64% yield, w/w). The water decoction was
prepared to mimic the traditional preparation process used by the Papua populations
in Indonesia [9 ].
Enriched extract used in clinical trials
The enriched extract used in the clinical studies was a dosage of a capsule containing
450 mg of the dry 70% ethanol leaf extract [12 ]
[17 ]. These capsules were prepared and delivered by the Department of Pharmacognosy and
Phytochemistry, Faculty of Pharmacy, University of Airlangga. The protocol for using
the capsules in the clinical trials requires the administration of one capsule a day
for 30 days.
For the purpose of dereplication, an enriched extract was prepared according to the
same acid-base extraction procedure used for the clinical trials [12 ]. J. gendarussa leaf powder collected in Pacet, Mojokerto, East Java, Indonesia was macerated with
acidified water, (100 mL, pH 3, HCl) 3×24 h using a shaker at room temperature (20±3+°C).
The plant material residue was washed with running water until it reached a pH of
6. An aliquot of the residue was extracted with 70% ethanol (3×24 h) by maceration
and checked for the presence of alkaloids by TLC, using Dragendorff until the results
were negative [20 ]. The filtrate obtained was evaporated at 40°C using a rotary evaporator (Büchi).
This process obtained a 70% ethanol extract of the J. gendarussa leaves. The dried extract was kept at 4+°C until the analyses were performed. HPLC-PDA-ELSD
analyses revealed that the enriched extract obtained was qualitatively similar to
the capsules used in the clinical studies (results not shown).
HPLC-PDA-ELSD analysis
HPLC-PDA-ELSD analyses were conducted on an HP 1100 system equipped with a photodiode
array detector (Agilent Technologies) connected to an ELSD Sedex 85 (Sedere). The
HPLC conditions were as follows: X-Bridge C18 column (250×4.6 mm i.d., 5 μm, Waters); solvent system MeOH (B) and H2 O (A), both containing 0.1% FA; gradient elution 0 min 5% B, 5 to 20% B in 10 min,
20% to 100% B in 30 min. Flow rate 1 mL/min; injection volume 10 μL; sample concentration
10 mg/mL in the mobile phase. The UV absorbance was measured at 254 nm and the UV-PDA
spectra were recorded between 190 and 600 nm (step 2 nm). The ELSD detection parameters
were as follows: pressure 3.5 bar, 45+°C, split to provide a 500-μL/min flow rate,
gain 8. This method was used for the profiling and main components’ quantitation.
UHPLC-TOF-HRMS analysis
UPLC-TOF-HRMS analyses were performed on a Waters Acquity UPLC system coupled to a
Waters Micromass-LCT Premier time-of-flight mass spectrometer, equipped with an electrospray
interface (ESI). The ESI conditions were as follows: capillary voltage 2800 V, cone
voltage 40 V, MCP detector voltage 2400 V, source temperature 120+°C, desolvation
temperature 300+°C, cone gas flow 20 L/h, desolvation gas flow 600 L/h. Detection
was performed in the negative ion mode with an m/z range of 100-1000 Da and a scan time of 0.5 s in the W-mode. The MS was calibrated
using sodium formate. Leucine enkephalin (Sigma-Aldrich) was used as an internal reference
at 2 μg/mL and infused through a Lock Spray probe at a flow rate of 10 μL/min aided
by a second LC pump. The separation was performed on an Acquity BEH C18 UHPLC column (50×1 mm i.d., 1.7 μm; Waters) using a linear gradient of H2 O (A) and acetonitrile (B), both containing 0.1% FA. The gradient elution was from
5 to 95% B in 4 min and the flow rate was 0.3 mL/min. The temperature was set at 30+°C
and the injection volume was setat 1 μL.
Compound isolation
The HPLC conditions used for the gradient transfer to MPLC (reversed-phase medium-pressure
liquid chromatography) were as follows: Zeoprep C18 column (250×4.6 mm i.d., 15-25 μm; Zeochem); mobile phase: H2 O (A) and MeOH (B), both containing 0.1% FA; gradient elution: 0-5% of B in 3 min
followed by 20% B for 23 min, hold 20% B for 5 min (25 min), increase B until 30%
during next 10 min (38 min), hold 30% B for 10 min (48 min), increase B content until
35% for 10 min (58 min), hold 35% until 75 min, at 78 min B content is 50 %, hold
for 10 min (88 min), increase B to 70% (98 min), hold 70% B for the next 10 min, and,
finally, increase B level until it is 100% (118 min). The flow rate was 1 mL/min.
The injection volume was 20 μL and the sample concentration was 10 mg/mL in the mobile
phase. The samples were analysed with UV detection, and the absorbance was measured
at 254 nm and ELSD detection. The ELSD detection parameters were as follows: pressure
3.5 bar, 45+°C, split to provide a 500-μL/min flow rate, gain 8.
The crude methanol extract (3 g) was fractionated using MPLC with Zeoprep C18 (920×49 mm i.d., 25 μm, Zeochem); mobile phase: MeOH (B) and H2 O (A), both containing 0.1% FA as the mobile phase in gradient mode, as above. The
flow rate was 8 mL/min, and the UV absorbance was detected at 254 nm. In total, 300
fractions were collected. All fractions were analysed using UPLC-TOF-MS. The purity
of compounds 1 -7 was estimated using HPLC-ELSD and UPLC-TOF-MS (results not shown), and the ELSD profiles
of compounds 4 -6 are shown in Fig. 9S , Supporting Information.
Compound characterization
Justidrusamide E (1 ). Amorphous white powder. [α ] D
20 +4.1° (c 0.96, MeOH); UV (MeOH); λmax (log ε ) nm: 220 (sh), 276 (4.8). 1 H NMR (DMSO-d
6 , 500 MHz) δ 1.04 (3 H, d, J =6.4 Hz, CH3 -13), 1.05 (3 H, d, J =6.4 Hz, CH3 -11), 2.00 (1 H, t, J =10.4 Hz, H-2'b), 2.33 (2 H, m, H-2'a, 3'b), 2.54 (1 H, m, H-3'a), 3.88 (2 H, q, J =6.4 Hz, H-10, 12), 4.94 (2 H, s, H-7), 5.14 (1 H, d, J =4.5 Hz, H-4'), 6.76 (1 H, dd, J =8.5, 2.9 Hz, H-4), 7.00 (1 H, d, J =2.9 Hz, H-6), 7.05 (1 H, d, J =8.5 Hz, H-3). 13 C NMR (DMSO-d
6 , 126 MHz) δ 17.7 (C-11, 13), 24.7 (C-2'), 28.4 (C-3'), 62.2 (C-7), 68.5 (C-10, 12), 83.2 (C-9),
93.0 (C-4'), 114.7 (C-4), 115.1 (C-6), 126.7 (C-2), 128.9 (C-3), 135.2 (C-1), 156.9
(C-5), 173.8 (C-8), 174.2 (C-1'). ESI-HRMS m/z 368.1356 [M - H]- (calcd. for C17 H22 NO8
- , 368.1345, Δ ppm=3.0).
Preparation of samples for quantitation
Standard stock solutions (1000 µg/mL) of compounds 4 , 5 , and 6 were prepared separately by accurately weighing 10 mg of each compound, transferring
them into a volumetric flask (10 mL), and dissolving them in 10 mL of methanol under
sonication (1 min). Working solutions were prepared through serial dilutions of the
stock solutions in 70/30, v/v MeOH-H2 O in the range of concentrations for the calibration curve covering 1 to 800 µg/mL
for each compound [21 ]. Water decoction, enriched extract, and methanol extract stock solutions were prepared
by accurately weighing 200 mg of each sample, transferring them into a volumetric
flask (10 mL), and dissolving them in methanol (10 mL) under sonication (1 min). Working
solutions (10 mg/mL) were prepared using appropriate dilution of the stock solution
in 70/30, v/v MeOH-H2 O. All samples were prepared daily before the analyses. All samples were prepared
not earlier than a day before the analyses and were kept at 4+°C. All samples were
filtered through a 0.45-µm membrane filter before injection into the HPLC system.
Supporting information
HPLC-UV chemical profiles of the J. gendarussa methanol leave extract from various regions in Indonesia and water decoction, 1 H NMR spectrum of compound 1 , and COSY NMR spectrum of compound 1 are available as Supporting Information.
